Finance

Lists
Why is NVCT up ၅.၇၉%?
Dive Deeper
NVCT:NASDAQ
Nuvectis Pharma Inc
၂၁.၉၂ US$
+၅.၇၉%
(+၁.၂၀) 1D
၂၁.၇၀ US$
-၁.၀၀% (-၀.၂၂)
After hours
Closed: အောက် ၂, GMT-၄ ၁၆:၀၀:၀၀  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NVCT...
Open
၂၁.၁၁ US$
High
၂၂.၀၀ US$
Low
၂၁.၀၄ US$
Mkt. cap
၇၁.၄၂ ကုဋေ
Avg. vol.
၂.၁၅ သိန်း
Volume
၂.၀၈ သိန်း
52-wk high
၂၉.၂၈ US$
52-wk low
၅.၅၅ US$
EPS
-၁.၃၁ US$
Beta
-၀.၂၄
Shares outstanding
၃.၂၆ ကုဋေ
No. of employees
၁၆
Open
၂၁.၁၁ US$
High
၂၂.၀၀ US$
Low
၂၁.၀၄ US$
Mkt. cap
၇၁.၄၂ ကုဋေ
Avg. vol.
၂.၁၅ သိန်း
Volume
၂.၀၈ သိန်း
52-wk high
၂၉.၂၈ US$
52-wk low
၅.၅၅ US$
EPS
-၁.၃၁ US$
Beta
-၀.၂၄
Shares outstanding
၃.၂၆ ကုဋေ
No. of employees
၁၆
News stories
From web sources and news partners
Traders Union
Traders Union
·
ပြီးခဲ့သည့် ၂၂ မိနစ်
S&P500 has posted gains in nearly every November-through-June period since 1942, Lia Holmgren notes
TradingView
TradingView
·
ပြီးခဲ့သည့် ၁ နာရီ
Getty Images Delists From NYSE, Shares Begin Trading Over The Counter Market
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၁ နာရီ
What Was Actually At Stake In Kanzhun's 34% Slide
About Nuvectis Pharma Inc
CEO-
Employees၁၆
Founded၂၀၂၀
HeadquartersFort Lee, နယူးဂျာစီပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Analyst ratings
Based on 5 analysts giving stock ratings to NVCT in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for NVCT in the last 3 months.
Highest
Current ၂၁.၉၂ US$
၃၉.၀၀ US$ (+၇၇.၉၂%)
Average
၃၄.၀၀ US$ (+၅၅.၁၁%)
Lowest
၃၀.၀၀ US$ (+၃၆.၈၆%)
Analyst
Recommendation
Action
Price target
Projected
Date
Naz Rahman
Maxim Group
Buy
Reiterated
၃၀.၀၀ US$
+၃၆.၉%
09/25/2026
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
၃၉.၀၀ US$
+၇၇.၉%
09/24/2026
Pete Stavropoulos
Cantor Fitzgerald
Buy
Initiated
-
-
08/24/2026
Christopher Liu
Lucid Capital
Buy
Maintained
၃၄.၀၀ US$
+၅၅.၁%
08/05/2026
Jonathan Aschoff
Roth MKM
Buy
Reiterated
၃၃.၀၀ US$
+၅၀.၅%
07/06/2026
Unknown Analyst
Roth MKM
Buy
Maintained
၂၀.၀၀ US$
-၈.၈%
06/23/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၅.၇၇ သန်း
၅.၀၉ သန်း
၄.၁၁ သန်း
၄.၆၈ သန်း
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၂.၀၂ သန်း
၂.၅၃ သန်း
၂.၁၅ သန်း
၂.၅၁ သန်း
Operating expense
၇.၇၉ သန်း
၇.၆၂ သန်း
၆.၂၆ သန်း
၇.၂၀ သန်း
Total operating expenses
၇.၇၉ သန်း
၇.၆၂ သန်း
၆.၂၆ သန်း
၇.၂၀ သန်း
Operating income
-၇.၇၉ သန်း
-၇.၆၂ သန်း
-၆.၂၆ သန်း
-၇.၂၀ သန်း
Other non operating income
-
-
-
-
EBT including unusual items
-၇.၄၆ သန်း
-၇.၃၁ သန်း
-၆.၀၅ သန်း
-၇.၀၂ သန်း
EBT excluding unusual items
-၇.၄၆ သန်း
-၇.၃၁ သန်း
-၆.၀၅ သန်း
-၇.၀၂ သန်း
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၇.၄၆ သန်း
-၇.၃၁ သန်း
-၆.၀၅ သန်း
-၇.၀၂ သန်း
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
၃.၃၂ သိန်း
၃.၀၃ သိန်း
၂.၁၀ သိန်း
၁.၇၇ သိန်း
Interest expense
-
-
-
-
Net interest expenses
၃.၃၂ သိန်း
၃.၀၃ သိန်း
၂.၁၀ သိန်း
၁.၇၇ သိန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ